We are working with MEDICIS to provide radiochemistry support and new primary activity standards. We will also supply reference materials, calibration sources and equipment loans to the project's researchers and use our measurement expertise to aid the radiochemical separation and calibration processes, ensuring that the creation of successful products is reproducible.
Working with CERN-MEDICIS gives a unique opportunity to establish optimised imaging protocols and primary radioactivity measurements at an earlier stage of development, ensuring maximum diagnostic potential is available for future clinical-trials and establishing the traceability needed to meet legislative requirements.
The potential results of the project could meet the urgent need for finding new innovative techniques capable of treating and a wide range of cancers. At first, the process will produce radioisotopes in small batches for use in institutions local to CERN, but the vision of the project is much larger and it is hoped that it will expand to cover a large global network.